Neurospongioblastomas are rare tumors that develop from neuroepithelial cells. They make up about 0.5-1% of all primary brain tumors. They are most common in children and young adults, but can occur at any age.
Neurospongioblastomas are usually round or oval in shape and can range in size from a few millimeters to several centimeters. They can be either single or multiple.
These tumors can occur in any part of the brain, but are most common in the frontal, temporal, and parietal lobes.
Treatment for neurospongioblastomas can be surgical, radiological, or a combination. In some cases, radiation therapy may be needed to shrink the tumor and improve its progress.
The prognosis for patients with neurospongioblastomas depends on many factors, including tumor size, location, and the presence of metastases. Some patients may live a long life after treatment, while others may die from complications or tumor progression.
In general, neurospongioblastoma is a complex tumor that requires complex treatment. However, thanks to modern diagnostic and treatment methods, many patients with this tumor can live long and healthy lives.
Neurospoggioblastoma is a malignant tumor of the nervous system: glial tissue, relatively rare, most often found in the subcortical nodes (thalamic and subthalamic-stem), sometimes found in the cerebellum, less often in the thalamus optic. The tumor can occur as bilateral. In such patients, the process progresses less, although over time it begins to grow into the corpus callosum, growing from the subcortical nuclei.